scPharmaceuticals Inc. (SCPH) NASDAQ

5.57

-0.01(-0.18%)

Updated at September 05 04:00PM

Currency In USD

scPharmaceuticals Inc.

Address

2400 District Avenue

Burlington, MA 01803

United States of America

Phone

617 517 0730

Sector

Healthcare

Industry

Biotechnology

Employees

162

First IPO Date

November 17, 2017

Key Executives

NameTitlePayYear Born
Mr. John H. TuckerPresident, Chief Executive Officer, Principal Executive Officer & Director1.05M1963
Ms. Rachael NokesChief Financial Officer632,1541976
Mr. Steve C. ParsonsSenior Vice President of Commercial0N/A
Dr. John Mohr Pharm.D.Senior Vice President of Clinical Development & Medical Affairs0N/A
Ms. Katherine TaudvinVice President of Corporate Affairs & Human Resources0N/A
Mr. Michael D. HassmanSenior Vice President of Technical Operations0N/A

Description

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.